Skip to content
Search

Latest Stories

New study reveals UK's painkiller capitals

A new study conducted by private  healthcare experts  MyTribeInsurance revealed that the North East and North Cumbria integrated care board ranked first in prescribing painkillers 142.69 times per one thousand patients monthly.

The board prescribed painkillers over 26.7 million times to its patients between April 2018 and March 2023, which cost the board over £136.9 million. The total number of patients in the North East and North Cumbria ICB is just over 3.1 million.


Second on the list is NHS Lincolnshire integrated care board prescribing painkillers 123.61 times per month per one thousand patients. This care board has just over 5.9 million patients, and the board prescribed painkillers over 5.9 million times, costing over £41.2 million between April 2018 and March 2023.

NHS South Yorkshire integrated care board ranked third, prescribing painkillers 120.28 times per month for every one thousand patients. The care board has over 1.4 million patients in its care, and this amount of prescribed painkillers cost over £68.9 million between April 2018 and March 2023, totalling just over 10.6 million times in that timeframe.

The fourth painkiller capital in the UK is Cheshire and Merseyside. The NHS Cheshire and Merseyside integrated care board prescribes analgesics on average 112.46 times per one thousand patients each month. Between April 2018 and March 2023, the care board prescribed painkillers 18 million times, costing over £114 million. The care board has just over 2.7 million patients.

The NHS Lancashire and South Cumbria integrated care board ranked fifth, spending over £76.7 million between April 2018 and March 2023 on painkillers being prescribed 11.8 million times. The care board has prescribed painkillers 110.49 times per month per one thousand patients, and there are 1.8 million patients in this ICB.

In sixth place is NHS Cornwall and The Isles of Scilly integrated care board, prescribing painkillers at a rate of 109.87 times per month per one thousand patients. In total painkillers were prescribed more than 3.8 million times between April 2018 and March 2023, costing over £24.5 million. There are just over 600 thousand patients within this board’s care.

Ranking in seventh place is NHS Humber and North Yorkshire integrated care board which has over 1.7 million patients. The total amount spent on the 11.3 million times painkillers were prescribed between April 2018 and March 2023 by the board was just over £78.1 million, and equates to 107.91 times per month per one thousand patients.

NHS Staffordshire and Stoke-on-Trent integrated care board ranks eighth, prescribing painkillers 107.8 times per month per one thousand patients. Over £55.9 million was spent on the 7.4 million times painkillers were prescribed between April 2018 and March 2023. There are over 1.1 million patients within this care board.

Ranking in ninth place is NHS Norfolk and Waveney integrated care board which has just over one million patients. The board prescribed painkillers 105.73 times per month per one thousand patients, which amounts to them prescribing painkillers 6.7 million times, totalling over £46.2 million between April 2018 and March 2023.

In tenth place is NHS Devon integrated care board which has over 1.2 million patients on the board. Painkillers are prescribed 105.63 times per one thousand patients per month; with the total cost between April 2018 and March 2023 coming to more than £51.8 million.

NHS North East and North Cumbria integrated care board prescribed the most painkillers in the UK between April 2018 and March 2023, totalling just over 26.7 million. It also has the second-highest number of patients in its care, with over 3.1 million. The NHS Greater Manchester integrated care board has the highest number of patients at around 3.2 million.

NHS Greater Manchester integrated care board spent the second-highest amount on painkillers between April 2018 and March 2023 in the UK, totalling over £121.6 million.

The UK area prescribing painkillers the fewest times per month per one thousand patients is the NHS North West London integrated care board, at a rate of 37.66.

London NHS integrated care boards, including North East, South East, North Central, South West and North West London, are prescribing painkillers the lowest rate, all at less than 50 times per month per one thousand patients.

A spokesperson for MyTribeInsurance commented on the findings: “This data offers a fascinating insight into the varying levels of painkiller prescriptions across England. There are various factors that might impact how many times analgesics might be prescribed in one area, such as the age of the population. Across the 42 integrated care boards that were included in the study, painkillers have been prescribed more than 300 million times in the past five years.”

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less